First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Recruiting · NCT07169318 · Registry updated 2026-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 1 | 2026-05-11 | NCT07169318 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Altasciences Inc - Kansas City | Overland Park | United States | 1 |